Clinical Trial Update: Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical trial evaluating the use of bivalirudin with stenting for long coronary lesions to prevent periprocedural myocardial nec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Bivalirudin (bivalirudin)

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Coronary Artery Disease | Phase 3 | Status: UNKNOWN